Sökning: WFRF:(Haggar A.)
> (2015-2019) >
Six-week follow-up ...
Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
-
- Gaines, Hans (författare)
- Karolinska Institutet,Public Health Agency of Sweden, Solna, Sweden; Dept Med, Infect Dis Unit, Karolinska Institute, Stockholm, Sweden; Dept Infect Dis, Karolinska Univ Hosp, Stockholm, Sweden
-
- Albert, Jan (författare)
- Karolinska Institutet,Swedish Reference Group for Antiviral Therapy,Karolinska University Hospital,Dept Microbiol Tumor & Cell Biol, Karolinska Institute, Stockholm, Sweden; Dept Clin Microbiol, Karolinska Univ Hosp, Stockholm, Sweden; Swedish Reference Grp Antiviral Therapy, Stockholm, Sweden
-
- Axelsson, Maria (författare)
- Folkhälsomyndigheten,Public Health Agency of Sweden,Public Health Agency of Sweden, Solna, Sweden
-
visa fler...
-
- Berglund, Torsten (författare)
- Karolinska Institutet
-
- Gisslén, Magnus, 1962 (författare)
- Gothenburg University,Göteborgs universitet,University of Gothenburg,Swedish Reference Group for Antiviral Therapy,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine,Swedish Reference Grp Antiviral Therapy, Stockholm, Sweden; Dept Infect Dis, Sahlgrenska Acad, Univ Gothenburg, Gothenburg, Sweden
-
- Sonnerborg, A. (författare)
- Karolinska Institutet,Swedish Reference Group for Antiviral Therapy,Karolinska University Hospital,Dept Infect Dis, Karolinska Univ Hosp, Stockholm, Sweden; Dept Clin Microbiol, Karolinska Univ Hosp, Stockholm, Sweden; Swedish Reference Grp Antiviral Therapy, Stockholm, Sweden; Div Clin Microbiol, Dept Lab Med, Karolinska Institute, Stockholm, Sweden
-
- Blaxhult, Anders (författare)
- Karolinska Institutet
-
- Bogdanovic, Gordana (författare)
- Karolinska universitetssjukhuset,Karolinska University Hospital,Dept Clin Microbiol, Karolinska Univ Hosp, Stockholm, Sweden
-
- Brytting, Maria (författare)
- Folkhälsomyndigheten,Public Health Agency of Sweden,Public Health Agency of Sweden, Solna, Sweden
-
- Carlander, Christina (författare)
- Karolinska Institutet
-
- Flamholc, Leo (författare)
- Lund University,Lunds universitet,Enheten för infektionssjukdomar,Forskargrupper vid Lunds universitet,Infectious Diseases Research Unit,Lund University Research Groups,Swedish Reference Group for Antiviral Therapy,Swedish Reference Grp Antiviral Therapy, Stockholm, Sweden; Dept Infect Dis, Skåne Univ Hosp, Lund Univ, Malmö, Sweden
-
- Follin, Per (författare)
- Västra Götalandsregionen,Region Västra Götaland,The County of Västra Götaland,Dept Communicable Dis Control & Prevent, Region Västra Götaland, Gothenburg, Sweden
-
- Haggar, Axana (författare)
- Socialstyrelsen,National Board of Health and Welfare,Socialstyrelsen / Swedish National Board of Health and Welfare,Natl Board Hlth & Welf, Stockholm, Sweden
-
- Hagstam, Per (författare)
- Lund University,Lunds universitet,Infektionsmedicin,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Infection Medicine (BMC),Section III,Department of Clinical Sciences, Lund,Faculty of Medicine,Dept Communicable Dis Control & Prevent, Malmö, Sweden
-
- Johansson, Marcus, 1975 (författare)
- Kalmar County Hospital,Dept Clin Microbiol & Infect Dis, Kalmar Cty Hosp, Kalmar, Sweden
-
- Navér, Lars (författare)
- Karolinska Institutet,Karolinska University Hospital,Swedish Reference Group for Antiviral Therapy,Swedish Reference Grp Antiviral Therapy, Stockholm, Sweden; Dept Pediat, Karolinska Univ Hosp, Stockholm, Sweden; Dept Clin Sci Intervent & Technol, Karolinska Institute, Stockholm, Sweden
-
- Persson Blom, Jenny (författare)
- Swedish Reference Group for Antiviral Therapy,Swedish Work Environment Authority, Stockholm, Sweden
-
- Samuelson, Agneta (författare)
- Karolinska Institutet
-
- Ström, Helena, 1985 (författare)
- Socialstyrelsen,National Board of Health and Welfare,Socialstyrelsen / Swedish National Board of Health and Welfare,Natl Board Hlth & Welf, Stockholm, Sweden
-
- Sundqvist, Martin (författare)
- Region Örebro län,Clin Microbiol, Örebro University Hospital, Örebro, Sweden
-
- Svedhem Johansson, Veronica (författare)
- Karolinska Institutet
-
- Tegmark Wisell, Karin (författare)
- Karolinska Institutet,Public Health Agency of Sweden, Solna, Sweden
-
- Tegnell, Anders (författare)
- Karolinska Institutet,Public Health Agency of Sweden, Solna, Sweden
-
- Thorstensson, Rigmor (författare)
- Karolinska Institutet,Public Health Agency of Sweden, Solna, Sweden
-
visa färre...
-
(creator_code:org_t)
- 2015-09-28
- 2016
- Engelska.
-
Ingår i: Infectious Diseases. - : Informa UK Limited. - 2374-4235 .- 2374-4243. ; 48:2, s. 93-98
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
http://www.ncbi.nlm....
-
https://research.cha...
-
https://doi.org/10.3...
-
https://lup.lub.lu.s...
-
https://gup.ub.gu.se...
-
https://urn.kb.se/re...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- In 2014 the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy (RAV) conducted a review and analysis of the state of knowledge on the duration of follow-up after exposure to human immunodeficiency virus (HIV). Up until then a follow-up of 12 weeks after exposure had been recommended, but improved tests and new information on early diagnosis motivated a re-evaluation of the national recommendations by experts representing infectious diseases and microbiology, county medical officers, the RAV, the Public Health Agency, and other national authorities. Based on the current state of knowledge the Public Health Agency of Sweden and the RAV recommend, starting in April 2015, a follow-up period of 6 weeks after possible HIV-1 exposure, if HIV testing is performed using laboratory-based combination tests detecting both HIV antibody and antigen. If point-of-care rapid HIV tests are used, a follow-up period of 8 weeks is recommended, because currently available rapid tests have insufficient sensitivity for detection of HIV-1 antigen. A follow-up period of 12 weeks is recommended after a possible exposure for HIV-2, since presently used assays do not include HIV-2 antigens and only limited information is available on the development of HIV antibodies during early HIV-2 infection. If pre- or post-exposure prophylaxis is administered, the follow-up period is recommended to begin after completion of prophylaxis. Even if infection cannot be reliably excluded before the end of the recommended follow-up period, HIV testing should be performed at first contact for persons who seek such testing.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
Nyckelord
- hiv follow-up window period
- prophylaxis
- hiv-2
- hiv-1
Publikations- och innehållstyp
- for (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Gaines, Hans
-
Albert, Jan
-
Axelsson, Maria
-
Berglund, Torste ...
-
Gisslén, Magnus, ...
-
Sonnerborg, A.
-
visa fler...
-
Blaxhult, Anders
-
Bogdanovic, Gord ...
-
Brytting, Maria
-
Carlander, Chris ...
-
Flamholc, Leo
-
Follin, Per
-
Haggar, Axana
-
Hagstam, Per
-
Johansson, Marcu ...
-
Navér, Lars
-
Persson Blom, Je ...
-
Samuelson, Agnet ...
-
Ström, Helena, 1 ...
-
Sundqvist, Marti ...
-
Svedhem Johansso ...
-
Tegmark Wisell, ...
-
Tegnell, Anders
-
Thorstensson, Ri ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Infektionsmedici ...
- Artiklar i publikationen
-
Infectious Disea ...
- Av lärosätet
-
Chalmers tekniska högskola
-
Lunds universitet
-
Göteborgs universitet
-
Örebro universitet
-
Karolinska Institutet